Our findings describe, at least partially, the role and mechanism of NEDD4-1 in conferring drug chemoresistance through the attenuation of PTEN and the subsequent hyperactivity of the AKT/NRF2/HO-1 signaling cascade in GBM. The gene discussed is NEDD4; the disease is glioblastoma.